UBS discloses higher voting rights in kidney-diagnostics firm Renalytix
UBS Group disclosed an increased voting-rights position in Renalytix after acquiring voting rights, with the notification identifying UBS AG as the shareholder holding the interest. The regulatory filing by Renalytix drew renewed market attention to the kidney-disease diagnostics company’s digital healthcare activities and highlighted the controlled-ownership chain behind the holding.